Dijkstra G - Search Results

1

Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays.

Vande Casteele N, Buurman DJ, Sturkenboom MG, Kleibeuker JH, Vermeire S, Rispens T, van der Kleij D, Gils A, Dijkstra G. Vande Casteele N, et al. Among authors: dijkstra g. Aliment Pharmacol Ther. 2012 Oct;36(8):765-71. doi: 10.1111/apt.12030. Epub 2012 Aug 28. Aliment Pharmacol Ther. 2012. PMID: 22928581

2

Titres of anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease are not related to disease activity.

Roozendaal C, Pogány K, Hummel EJ, Horst G, Dijkstra G, Nelis GF, Limburg PC, Kleibeuker JH, Kallenberg CG. Roozendaal C, et al. Among authors: dijkstra g. QJM. 1999 Nov;92(11):651-8. doi: 10.1093/qjmed/92.11.651. QJM. 1999. PMID: 10542305

3

Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens.

Haagsma EB, Van Den Berg AP, Kleibeuker JH, Slooff MJ, Dijkstra G. Haagsma EB, et al. Among authors: dijkstra g. Aliment Pharmacol Ther. 2003 Jul 1;18(1):33-44. doi: 10.1046/j.1365-2036.2003.01613.x. Aliment Pharmacol Ther. 2003. PMID: 12848624

4

[Gene therapy with interleukin 10 in Crohn's disease: too early yet].

Dijkstra G, Hospers GA, Kleibeuker JH. Dijkstra G, et al. Ned Tijdschr Geneeskd. 2003 Nov 1;147(44):2153-6. Ned Tijdschr Geneeskd. 2003. PMID: 14626830 Dutch.

5

[Treatment of servere ulcerative colitis].

Weersma RK, van Dullemen HM, Kleibeuker JH, Ploeg RJ, Dijkstra G. Weersma RK, et al. Among authors: dijkstra g. Ned Tijdschr Geneeskd. 2006 Jan 7;150(1):12-7. Ned Tijdschr Geneeskd. 2006. PMID: 16440618 Review. Dutch.

6

Review article: Inflammatory bowel disease and genetics.

Weersma RK, van Dullemen HM, van der Steege G, Nolte IM, Kleibeuker JH, Dijkstra G. Weersma RK, et al. Among authors: dijkstra g. Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:57-65. doi: 10.1111/j.1365-2036.2007.03476.x. Aliment Pharmacol Ther. 2007. PMID: 18081650 Review.

7

Microscopic colitis: an unfamiliar but treatable disease.

van der Wouden EJ, Karrenbeld A, Kleibeuker JH, Dijkstra G. van der Wouden EJ, et al. Among authors: dijkstra g. Neth J Med. 2009 Feb;67(2):41-5. Neth J Med. 2009. PMID: 19299845 Free article. Review.

8

Letter: detection of infliximab levels and anti-infliximab antibodies--comparison of three different assays; authors' reply.

Buurman DJ, Vande Casteele N, Sturkenboom MG, Kleibeuker JH, Vermeire S, van der Kleij D, Rispens T, Gils A, Dijkstra G. Buurman DJ, et al. Among authors: dijkstra g. Aliment Pharmacol Ther. 2013 Jan;37(2):282. doi: 10.1111/apt.12128. Aliment Pharmacol Ther. 2013. PMID: 23252783 No abstract available.

9

Population pharmacokinetics of infliximab in patients with inflammatory bowel disease: potential implications for dosing in clinical practice.

Buurman DJ, Maurer JM, Keizer RJ, Kosterink JG, Dijkstra G. Buurman DJ, et al. Among authors: dijkstra g. Aliment Pharmacol Ther. 2015 Sep;42(5):529-39. doi: 10.1111/apt.13299. Epub 2015 Jun 26. Aliment Pharmacol Ther. 2015. PMID: 26113313

10

Letter: infliximab therapy for patients with inflammatory bowel disease--some unanswered questions. Authors' reply.

Buurman DJ, Maurer JM, Keizer RJ, Kosterink JG, Dijkstra G. Buurman DJ, et al. Among authors: dijkstra g. Aliment Pharmacol Ther. 2015 Nov;42(9):1134. doi: 10.1111/apt.13396. Aliment Pharmacol Ther. 2015. PMID: 26427756 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters